A large pharma manufacturer engaged with our Advisors to better understand and develop an engagement strategy for influential customers with developing specialty pharmacy capabilities. The outcome of the engagement was the development of a process for determining whether to grant such organizations access to the manufacturer’s limited distribution therapies.
- Conducted Voice of the Customer meetings with major health system/IDNs, academic institutions and provider-owned dispensing entities that have developed or are developing specialty pharmacy capabilities
- Developed an Exception Access Strategy and Process involving a cross-functional team from the manufacturer
- Developed capacity to evaluate and contract with approved “exception access” entities